Medicine, Rheumatology Division

Grants

Grants per year 1993 2002 2007 2008 2010 2011 2013 2014 2015 2016 2017 2018 2019 2020 2021 2027

• 1 Not started
• 78 Active
• 356 Finished

Grants per year

Search results

• Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships

  Ramsey-Goldman, R.

  American College of Rheumatology, Centers for Disease Control and Prevention

  10/1/20 → 9/23/22

  Project: Research project

  • public awareness campaign 100%
  • plan 39%
  • program 30%
  • project 30%

• Training to Increase Minority Enrollment in Lupus Clinical Trials with CommunitY Engagement (TIMELY)

  Ramsey-Goldman, R.

  American College of Rheumatology, Office of the Assistant Secretary for Health

  10/1/21 → 9/29/22

  Project: Research project

  • opinion leader 100%
  • Clinical Trials 60%
  • minority 52%
  • grant 31%
  • website 30%

• A Phase II Sequential Dose-escalation Study Evaluating the Safety and Feasibility of Allogenlc Umbillcal Cord Derived Mesenchymal Stromal Cells for the Treatment of Adults w/ Treatment Refractory Lupus Dr. Rosalind Ramsey-Goldman - Rheumatology (Medical U

  Ramsey-Goldman, R., Ghossein, C. & Mahieu, M. A.

  Medical University of South Carolina, Lupus Foundation of America, Inc.

  10/1/21 → 9/30/22

  Project: Research project

  • Data Management 100%
  • Facilities and Services Utilization 87%
  • Budgets 85%
  • Rheumatology 81%
  • Research Ethics Committees 78%

• A Phase II Sequential Dose-escalation Study Evaluating the Safety and Feasibility of Allogenlc Umbillcal Cord Derived Mesenchymal Stromal Cells for the Treatment of Adults w/ Treatment Refractory Lupus

  Ramsey-Goldman, R., Ghossein, C. & Mahieu, M. A.

  Medical University of South Carolina, Lupus Foundation of America, Inc.

  10/1/19 → 9/30/22

  Project: Research project

  • Data Management 100%
  • Facilities and Services Utilization 87%
  • Budgets 85%
  • Research Ethics Committees 78%
  • Mesenchymal Stem Cells 67%

• The Role of Monocytes and Macrophages in a Murine Model of SSc

  Perlman, H. R., Makinde, H. M. & Winter, D. R.

  Syndax Pharmaceuticals Inc.

  10/1/21 → 9/30/22

  Project: Research project

  • Monocytes 100%
  • Macrophages 84%
  • RNA-Seq 70%
  • Bleomycin 68%
  • Population 23%

• A Phase II Sequential Dose-escalation Study Evaluating the Safety and Feasibility of Allogenlc Umbillcal Cord Derived Mesenchymal Stromal Cells for the Treatment of Adults w/ Treatment Refractory Lupus

  Ramsey-Goldman, R., Ghossein, C. & Mahieu, M. A.

  Medical University of South Carolina, Lupus Foundation of America, Inc.

  10/1/20 → 9/30/22

  Project: Research project

  • Refractory materials 100%
  • Data Center 74%
  • Interval 53%
  • Safety 51%
  • Dose 49%

• Prot #HGS1006-C1124: A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated with or without BENLYSTA™ (belimumab)

  Hsieh, C.

  Outcome Sciences Inc., GlaxoSmithKline LLC

  10/9/14 → 10/10/22

  Project: Research project

• Prot #ES-301: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)

  Correia, C. S.

  Medpace Clinical Research LLC, Eicos Sciences, Inc.

  10/14/19 → 10/14/22

  Project: Research project

• Wnt-beta-catenin cross interactions in alveolar macrophages and epithelial cells in persistence of SSc-ILD

  Dematte D'Amico, J. E., Gottardi, C., Hinchcliff, M. E., Lam, A. P., Berdnikovs, S., Budinger, G. S., Dematte D'Amico, J. E., Hinchcliff, M. E. & Misharin, A.

  National Heart, Lung, and Blood Institute

  12/22/17 → 11/30/22

  Project: Research project

  • Systemic Scleroderma 100%
  • Interstitial Lung Diseases 88%
  • Alveolar Macrophages 60%
  • Cats 58%
  • Alveolar Epithelial Cells 53%

• A Coproduced Symptom Monitoring Dashboard to Increase Shared Decision-Making in Rheumatoid Arthritis

  Peipert, D., Greene, G. J., Lee, Y. C. & Tegel, K. K.

  Pfizer Inc.

  12/18/19 → 12/18/22

  Project: Research project

  • Shared Decision Making 100%
  • Rheumatoid Arthritis 77%
  • Health 45%
  • Patient Reported Outcome Measures 44%
  • Medicine 24%

• Prot# 02-021: The CORRONA Data Collection Program (#02-021)

  Ruderman, E. M.

  Corrona, LLC

  2/6/05 → 12/31/22

  Project: Research project

• Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center

  Wunderink, R. G., Abdala-Valencia, H., Bartom, E. T., Budinger, G. S., Davuluri, R. V., Horvath, C. M., Kandpal, M., Misharin, A., Ozer, E. A., Qi, C., Singer, B., Wehbe, F., Winter, D. R., Amaral, L. A. N., Hauser, A. R. & Starren, J. B.

  National Institute of Allergy and Infectious Diseases

  1/17/18 → 12/31/22

  Project: Research project

  • Pneumonia 100%
  • Systems Biology 98%
  • Phenomics 78%
  • Microbiota 67%
  • Biomarkers 59%

• The Role of Placental Maternal Vascular Underperfusion in Neonatal Pulmonary Hypertension

  Mestan, K. K. L., Grobman, W. A., Misharin, A. & Swaminathan, S.

  Ann & Robert H. Lurie Children's Hospital of Chicago, National Heart, Lung, and Blood Institute

  6/1/19 → 1/31/23

  Project: Research project

  • Pulmonary Hypertension 100%
  • Bronchopulmonary Dysplasia 88%
  • Mothers 67%
  • Blood Vessels 65%
  • Fetal Blood 58%

• Prot #JBT101-DM-002: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

  Hsieh, C.

  Corbus Pharmaceuticals, Inc.

  1/22/19 → 2/22/23

  Project: Research project

• Comprehensive Characterization and Contribution of the Keratinocytes-Fibroblasts Crosstalk in 3D-Scleroderma Skin Equivalent

  Bhattacharyya, S., Perez White, B. E. & Varga, J.

  Boehringer Ingelheim Pharmaceuticals, Inc.

  3/13/20 → 3/13/23

  Project: Research project

• Role of Spleen educated monocytes in mediating ischemia-reperfusion injury following lung transplant

  Bharat, A., Budinger, G. S., Misharin, A., Winter, D. R. & Wu, Q.

  National Heart, Lung, and Blood Institute

  4/1/19 → 3/31/23

  Project: Research project

  • Monocytes 100%
  • Spleen 68%
  • Reperfusion Injury 66%
  • Lung Transplantation 48%
  • Transplants 45%

• Spontaneous cardiac fibrosis in PAI-1-deficient mice and men: A rare mutation informs a common molecular pathophysiology

  Vaughan, D. E., Burridge, P., Carr, J., Eren, M., Flevaris, P. D., Ghosh, A. K., Hou, L., Khan, S. S., Shah, S. J., Wilsbacher, L. D. & Winter, D. R.

  National Heart, Lung, and Blood Institute

  4/15/19 → 3/31/23

  Project: Research project

  • Plasminogen Activator Inhibitor 1 100%
  • Plasminogen Activator Inhibitor-1 Deficiency 82%
  • Fibrosis 77%
  • Cardiomyopathies 43%
  • Cardiac Myocytes 41%

• Disordered Tissue Biomechanics as a Driver of Esophageal Disease

  Pandolfino, J. E., Tetreault, M., Budinger, G. S., Carlson, D. A., Ciolino, J. D., Hinchcliff, M. E., Hirano, I., Passman, R. S., Taft, T. N., Yang, G., Espinosa, H. D., Gonsalves, N. P., Kahrilas, P. J. & Patankar, N. A.

  National Institute of Diabetes and Digestive and Kidney Diseases

  7/15/18 → 6/30/23

  Project: Research project

  • Esophageal Diseases 100%
  • Deglutition Disorders 70%
  • Biomechanical Phenomena 51%
  • Esophagus 48%
  • Mechanical Phenomena 26%

• Postdoctoral Rheumatology Training

  Perlman, H. R. & Pope, R. M.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/1/17 → 6/30/23

  Project: Research project

  • Schools of medicine 100%
  • trainee 78%
  • administrative structure 52%
  • basic research 47%
  • etiology 44%

• Lupus Intervention Fatigue Trial (LIFT)

  Ramsey-Goldman, R., Chang, R. W., Chmiel, J. S., Cuda, C. M., Dunlop, D. D., Mahieu, M. A., Perlman, H. R., Rothrock, N. E., Spring, B., Van Horn, L. & Yount, S.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  8/1/18 → 7/31/23

  Project: Research project

  • Fatigue 100%
  • Exercise 26%
  • Diet 22%
  • Motivational Interviewing 21%
  • Nutrients 20%

• The Robert H. Lurie Comprehensive Cancer Center

  Platanias, L. C., Arvanitis, C., Bonini, M., Butt, Z., Kocherginsky, M., Kumthekar, P. U., Rini, C., Shilatifard, A., Wignall, S., Zhang, Z., Agulnik, M., Awatramani, R., Backman, V., Benson III, A. B., Carthew, R. W., Cella, D., Chakravarti, D., Chandel, N., Crispino, J. D., Cristofanilli, M., Eklund, E. A., Frankfurt, O., Gordon, L. I., Green, K. J., Hahn, E. A., Hitsman, B. L., Horbinski, C. M., Horvath, C. M., Hussain, M., James, C. D., Kelleher, N. L., Khan, S. A., LaBonne, C., Larson, A. C., Matei, D. E., Meade, T. J., Mondragon, A., Mrksich, M., Munshi, H. G., Murphy, A. B., Obeng, R., Penedo, F. J., Perlman, H. R., Peter, M. E., Rademaker, A. W., Rappoport, J. Z., Rosenzweig, A. C., Scheidt, K. A., Simon, M. A., Sosman, J. A., Spring, B., Wei, J., Weiss, E. L. & Woloschak, G. E.

  National Cancer Institute

  8/10/18 → 7/31/23

  Project: Research project

  • neoplasms 100%
  • medicine 25%

• Flow Cytometry Shared Resource

  Perlman, H. R.

  National Cancer Institute

  8/10/18 → 7/31/23

  Project: Research project

  • neoplasms 100%
  • flow cytometry 78%
  • medicine 28%

• Defining an epigenomic signature of myeloid skewing in hematopoietic stem cells as a risk factor for disease in aging.

  Winter, D. R.

  Burroughs Wellcome Fund

  9/1/20 → 8/31/23

  Project: Research project

  • recipient 100%
  • biomedical research 67%
  • medical research 66%
  • applicant 55%
  • Canada 40%

• Prot #JBT101-LTS-001: An Observational Long-Term Safety Surveillance Study of Participants from Corbus Sponsored Lenabasum Pivotal Clinical Trials

  Hsieh, C.

  Corbus Pharmaceuticals, Inc.

  9/15/20 → 9/15/23

  Project: Research project

• Increasing Minority Participation and Awareness in Clinical Trials+ (IMPACT+)

  Ramsey-Goldman, R.

  Lupus Foundation of America, Inc., Office of the Assistant Secretary for Health

  9/30/21 → 9/29/23

  Project: Research project

  • Rheumatology 100%
  • minority 62%
  • participation 46%
  • trial 43%
  • Video recording 33%